News Summary

  • Medtronic announced on Tuesday that it has developed an application for its Hugo surgical robot that supports AI-assisted decision-making during surgical procedures.
  • The Touch Surgery Aide platform integrates Nvidia's computing infrastructure and runs Medtronic's proprietary AI application, Instrument Exit Point (IEP). Medtronic stated that the application has received approval from the U.S. Food and Drug Administration (FDA).
  • Medtronic will preview this new platform this week at the Society of Robotic Surgery conference in Florida.

In-Depth Analysis

Medtronic received FDA clearance for its Hugo robot in urological surgery last December, becoming the first major medical technology company to challenge Intuitive Surgical's leading position in the U.S. robotic soft tissue surgery market. Since then, Medtronic has submitted applications seeking further FDA clearance for the Hugo robot in general surgery and gynecology specialties.

IEP is Medtronic's first real-time AI application for robotic surgery. According to the company, the Touch Surgery Aide computing platform expands Medtronic's Touch Surgery ecosystem, which is already used in over 1,500 operating rooms worldwide for preoperative planning, training, intraoperative remote guidance, and postoperative analysis.

"Real-time AI marks a new frontier in healthcare—this is a fundamental evolution in how surgery is supported, moving from technology that assists surgeons' hands to technology that helps teams work smarter, act faster, and have greater impact in the moment," said Jim Peichel, Medtronic's Chief Technology Officer, in a statement.

Touch Surgery Aide combines computer vision and AI to process surgical video and surgical data in real time. During live procedures, multiple AI applications can run simultaneously, and the system is designed to continuously learn and evolve.

IEP can issue visual notifications during robotic surgery when instruments exit the field of view. Medtronic stated that IEP is an early step in bringing AI support to robotic surgery, and the platform is designed to be expandable to laparoscopic surgery in the future.